Early Termination of Clinical Trials

"Early Termination of Clinical Trials" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Earlier than planned termination of clinical trials.

Descriptor ID	D057239
MeSH Number(s)	E05.581.500.400 N04.761.559.590.800.379 N05.715.360.575.575.800.379
Concept/Terms	Early Termination of Clinical Trials Early Termination of Clinical Trials

Below are MeSH descriptors whose meaning is more general than "Early Termination of Clinical Trials".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Methods [E05.581]
Research Design [E05.581.500]
Early Termination of Clinical Trials [E05.581.500.400]
Health Care [N]
Health Services Administration [N04]
Quality of Health Care [N04.761]
Outcome and Process Assessment (Health Care) [N04.761.559]
Outcome Assessment (Health Care) [N04.761.559.590]
Treatment Outcome [N04.761.559.590.800]
Early Termination of Clinical Trials [N04.761.559.590.800.379]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Outcome and Process Assessment (Health Care) [N05.715.360.575]
Outcome Assessment (Health Care) [N05.715.360.575.575]
Treatment Outcome [N05.715.360.575.575.800]
Early Termination of Clinical Trials [N05.715.360.575.575.800.379]

Below are MeSH descriptors whose meaning is related to "Early Termination of Clinical Trials".

Below are MeSH descriptors whose meaning is more specific than "Early Termination of Clinical Trials".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Early Termination of Clinical Trials" by people in this website by year, and whether "Early Termination of Clinical Trials" was a major or minor topic of these publications.

Bar chart showing 6 publications over 5 distinct years, with a maximum of 2 publications in 2021

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
2010	1	1
2011	1	1
2012	1	1
2013	1	1
2021	2	2

Below are the most recent publications written about "Early Termination of Clinical Trials" by people in Profiles.

McNamee JJ, Gillies MA, Barrett NA, Perkins GD, Tunnicliffe W, Young D, Bentley A, Harrison DA, Brodie D, Boyle AJ, Millar JE, Szakmany T, Bannard-Smith J, Tully RP, Agus A, McDowell C, Jackson C, McAuley DF. Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial. JAMA. 2021 09 21; 326(11):1013-1023.

View in: PubMed
Sevransky JE, Rothman RE, Hager DN, Bernard GR, Brown SM, Buchman TG, Busse LW, Coopersmith CM, DeWilde C, Ely EW, Eyzaguirre LM, Fowler AA, Gaieski DF, Gong MN, Hall A, Hinson JS, Hooper MH, Kelen GD, Khan A, Levine MA, Lewis RJ, Lindsell CJ, Marlin JS, McGlothlin A, Moore BL, Nugent KL, Nwosu S, Polito CC, Rice TW, Ricketts EP, Rudolph CC, Sanfilippo F, Viele K, Martin GS, Wright DW. Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial. JAMA. 2021 02 23; 325(8):742-750.

View in: PubMed
Tarhini AA, Zahoor H, McLaughlin B, Gooding WE, Schmitz JC, Siegfried JM, Socinski MA, Argiris A. Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer. Anticancer Res. 2013 Oct; 33(10):4475-81.

View in: PubMed
Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2012; 7:CD003426.

View in: PubMed
Moulder S, Gladish G, Ensor J, Gonzalez-Angulo AM, Cristofanilli M, Murray JL, Booser D, Giordano SH, Brewster A, Moore J, Rivera E, Hortobagyi GN, Tran HT. A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. Cancer. 2012 May 1; 118(9):2378-84.

View in: PubMed
Boussen H, Cristofanilli M, Zaks T, DeSilvio M, Salazar V, Spector N. Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer. J Clin Oncol. 2010 Jul 10; 28(20):3248-55.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement